Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations-Reference-Cited by-同舟云学术

Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations

Published:2021-08 Issue: Volume:158 Page:55-59
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Fekkar Amal,Emprou Camille^ORCID,Lefebvre Christine,Ferretti Gilbert,Stephanov Olivier,Pissaloux Daniel,Mc Leer Anne,Toffart Anne-Claire,Rousseaux Sophie^ORCID,Khochbin Saadi,Lantuejoul Sylvie,Valmary-Degano Séverine^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference11 articles.

1. NUT Carcinoma: clinicopathologic features, pathogenesis, and treatment: NUT Carcinoma;French;Pathol. Int.,2018

2. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody;Haack;Am. J. Surg. Pathol.,2009

3. NUT midline carcinoma;French;Cancer Genet. Cytogenet.,2010

4. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum;Evans;Am. J. Surg. Pathol.,2012

5. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients;Chau;JNCI Cancer Spectr.,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis;Frontiers in Oncology;2024-01-09

2. NUT carcinoma and thoracic SMARCA4‐deficient undifferentiated tumour: facts and controversies;Histopathology;2023-10-24

3. Towards a clinically applicable histomolecular classification of lung adenocarcinomas?;Translational Lung Cancer Research;2023-05

4. Challenging Metastatic Melanoma to the Lung With p40 Expression: A Diagnostic Pitfall, Case Report;Applied Immunohistochemistry & Molecular Morphology;2022-11-01

5. Diagnosis, Treatment and Prognosis of Primary Pulmonary NUT Carcinoma: A Literature Review;Current Oncology;2022-09-22